Results 121 to 130 of about 38,466 (239)
ABSTRACT Background Platelet‐rich plasma (PRP) is widely used in aesthetic and regenerative medicine; however, rare vision‐threatening complications such as blindness have been reported following facial injections. Aims This systematic review aimed to identify and analyze all published cases of visual impairment following PRP injections.
Mandana Ebrahimzade +6 more
wiley +1 more source
Is Thrombolytic Therapy Safe When Used to Treat Elderly Patients?
Recently, research has been conducted to determine if thrombolytic therapy works to dissolve clots and if it is a safe treatment option. The specific purpose of this study is to determine if thrombolytic therapy is safe for use in the elderly. This study
Yaeger, Daniel
core
Protocoled thrombolytic therapy for frostbite improves phalangeal salvage rates.
Background: Frostbite is a cold injury that has the potential to cause considerable morbidity and long-term disability. Despite the complexity of these patients, diagnostic and treatment practices lack standardization. Thrombolytic therapy has emerged as
Kloda, Daniel +5 more
core
Background: Reperfusion therapy is the standard treatment of acute myocardial infarction (AMI). If the percutaneous coronary intervention (PCI), as a preferred reperfusion strategy, was not available, thrombolytic therapy is chosen as an alternative ...
Hassan Shemirani +1 more
doaj
A, Bailey, J C, Lydon, F J, Spielman
openaire +2 more sources
Thrombolytic therapy for acute coronary obstruction: status in 1986 [PDF]
The effect of thrombolysis in acute myocardial infarction on enzymatic infarct size, left ventricular function, and early mortality was studied in subsets of patients in a randomized trial at The Netherlands Interuniversity Cardiological Institute during
Hugenholtz, P.G. (Paul) +3 more
core
Update on Thrombolytic Therapy in Acute Pulmonary Thromboembolism
Thrombolytic treatment accelerates the dissolution of thrombus in acute pulmonary thromboembolism (PTE) and is potentially a lifesaving treatment. High-risk PTE is the clearest indication for this therapy, and its use in intermediate-risk cases is still ...
YILMAZEL UÇAR, Elif, Elif Yilmazel Ucar
core +1 more source
BACKGROUND: Cardiovascular diseases are the major causes of mortality worldwide and acute myocardial infarction (AMI) is the leading cause of mortality among cardiovascular diseases. Thrombolytic therapies, especially during the first few hours after the
Mohammadreza Samieinasab +4 more
doaj
Feasibility of acute thrombolytic therapy for stroke
Background: Thrombolysis is an expensive medical intervention for ischemic stroke and hence there is a need to study the feasibility of thrombolysis in rural India. Aims: To asses the feasibility and limitations of providing thrombolytic therapy to acute
K. Nandigam +5 more
core +1 more source
Recent advances in intra-arterial thrombolysis
Thrombolytic therapy has revolutionized acute ischemic stroke (AIS) treatment; however it is clear that intravenous (IV) thrombolytic therapy has certain limitations, including a short-time window for use, poor specificity for the site of arterial ...
Bershad Eric, Suarez Jose
doaj

